What's the difference?

Different uses

Ozempic is prescribed for Type 2 diabetes. It lowers blood sugar by triggering insulin production when blood sugar is high, which helps prevent complications like nerve damage, kidney problems, and vision issues.

Wegovy targets weight management. It's prescribed for adults who are obese or overweight, especially with conditions like high blood pressure or high cholesterol. It produces significant weight loss, which improves overall health and lowers cardiovascular risk.

Doctors also use both drugs off-label:

• Ozempic: sometimes prescribed for weight loss in patients with Type 2 diabetes.
• Wegovy: sometimes prescribed in Type 2 diabetes patients for its weight loss benefits, which indirectly helps manage blood sugar.

Similar mechanisms

Both drugs slow down stomach emptying. This process, called gastric emptying, keeps food in the stomach longer so you feel full for longer. The result is less appetite and less food intake.

Both also reduce appetite by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which acts on the brain regions that control hunger. Cravings drop, and so does total food consumption.

Both improve insulin sensitivity, so the body uses insulin more effectively. That means better control of blood sugar spikes after meals and fewer diabetes complications.

How effective are Ozempic and Wegovy?

Weight loss comparison

Both drugs produce real weight loss, but Wegovy goes further. On average, Wegovy users lose around 15% of their body weight, while Ozempic users lose around 12%. Diet and exercise affect the numbers in either direction.

Dosage is a big part of the difference:

• Wegovy: 2.4 mg once weekly (typical maintenance dose).
• Ozempic: up to 2 mg once weekly.

Wegovy's higher dose is the main reason it produces more weight loss.

Diabetes management

Both drugs lower A1C, the standard measure of blood sugar control over the past three months.

• Ozempic: reduces A1C by about 1.5% to 2% on average.
• Wegovy: lowers A1C too, usually by 1% to 1.5%, even though it's not primarily a diabetes drug.

Both also cut cardiovascular risk:

• Ozempic: reduces major cardiovascular events by roughly 26%.
• Wegovy: offers similar benefits, especially in overweight or obese patients.

What the long-term studies show

• Ozempic: trials show sustained A1C reductions and weight loss over 52 weeks. Long-term use correlates with fewer heart attacks and strokes.
• Wegovy: patients can maintain significant weight loss for up to 68 weeks. Long-term data also suggests a big reduction in the risk of developing Type 2 diabetes.

What patients report:

• Ozempic: better blood sugar control and overall well-being. Some users cut back on or stop other diabetes medications.
• Wegovy: significant weight loss, better mobility, less weight-related pain, and more energy.

What are the side effects?

Common side effects

Same active ingredient, same mechanism, so the side effect profiles overlap.

Nausea and vomiting: common when starting the medication. The drugs slow stomach emptying, which can cause these symptoms. They usually ease as your body adjusts.

Diarrhea and constipation: changes in bowel habits are common because these drugs change how food moves through your digestive system.

Gastroparesis and kidney concerns: gastroparesis (delayed stomach emptying) is a more severe side effect, causing bloating, stomach pain, and severe nausea. Kidney problems can show up if dehydration from vomiting or diarrhea sets in. Kidney monitoring matters.

Severity of side effects

Wegovy's higher dose tends to produce more intense side effects than Ozempic. More semaglutide in your system can mean worse nausea, vomiting, and other gastrointestinal symptoms.

Long-term, most side effects ease over time, but some persist. Ongoing GI issues can cause nutritional deficiencies, and persistent kidney problems may need medical intervention.

Managing side effects

What helps:

• Start with a lower dose and ramp up gradually.
• Drink plenty of water to manage diarrhea and prevent dehydration.
• Eat smaller, more frequent meals to ease nausea.
• Skip spicy or fatty foods that worsen GI symptoms.

When to call your doctor:

• Persistent or severe symptoms like ongoing nausea, vomiting, or signs of dehydration.
• Pre-existing kidney problems or severe digestive issues.
• Any new or unusual symptoms.

Dosage and administration

Both drugs are subcutaneous injections from a pre-filled pen, taken with or without meals in the abdomen, thigh, or upper arm. The dosages differ. Ozempic starts at 0.25 mg once weekly and goes up to a max of 1 mg once weekly. Wegovy also starts at 0.25 mg once weekly, then steps up every four weeks (0.5 mg, 1 mg, 1.7 mg) to a maintenance dose of 2.4 mg once weekly.

How much do Ozempic and Wegovy cost?

Cost comparison

Both drugs are expensive. Without insurance, a monthly supply of Ozempic runs around $220 to $265. Wegovy is more, around $430 to $500 per month. Prices vary slightly by pharmacy and location. We usually recommend Costco Pharmacy, which typically has the best pricing.

Insurance changes the picture. Provincial insurance like OHIP doesn't cover either drug for weight loss in Canada, but private insurance through an employer often does. Coverage varies: Ozempic is more likely to be covered for Type 2 diabetes, while Wegovy gets covered for patients who meet specific weight management criteria. Check with your insurance provider.

Are generics available?

No generic version of either drug exists. Patients have to use manufacturer assistance programs or insurance coverage to manage cost. Generics may show up once patents expire and competition arrives.

The bottom line

Wegovy and Ozempic share the same active ingredient (semaglutide) and work the same way, but they're prescribed and marketed differently (though doctors sometimes prescribe either off-label for weight management):

1. Health Canada-approved uses: Wegovy is approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, as well as for children 12 and older with obesity. Ozempic is primarily approved for treating type 2 diabetes in adults and reducing cardiovascular risk in adults with type 2 diabetes and known heart disease.
2. Injection pens: Wegovy pens are single-use with built-in needles, while Ozempic pens contain multiple doses and require attaching needles before each use.
3. Cost: Wegovy tends to be more expensive compared to Ozempic.
4. Insurance coverage: Due to their different approved uses, Wegovy is more likely to be covered for weight loss, while Ozempic is typically covered for diabetes but not weight loss.
5. Effectiveness for weight loss: Although both can lead to weight loss, Wegovy's higher maximum dose (2.4 mg) tends to result in greater average weight loss compared to Ozempic's typical maintenance dose (1 mg).
6. Pediatric use: Wegovy is FDA-approved for weight loss in children 12 and older, while Ozempic is not approved for any uses in children under 18 (though it may be prescribed off-label in some cases).

How to choose between Ozempic and Wegovy

Both drugs are semaglutide, but their approvals differ. Cost and insurance coverage usually drive the decision. Wegovy is more expensive at retail, but if your insurance covers it for weight loss, it's often the better choice (Ozempic isn't covered for weight loss). It's also worth looking at other GLP-1 agonists like Saxenda, Rybelsus, and Mounjaro, which may have different benefits or better insurance coverage. Talk to a healthcare provider to find the right option for your health and budget.

Disclaimer: This blog post is intended for educational purposes only and should not be taken as medical advice. Always consult your healthcare provider for personal health concerns.